Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual testosterone for sexual arousal in premenopausal women with HSDD
2010-019540-39Phase 2Active
- Sponsor
- Emotional Brain
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of testosterone in hypoactive sexual desire disorder (HSDD), Sexual Arousal Disorder and sexual dysfunction (2 arms), sponsored by Emotional Brain. Primary endpoints: Physiological sexual arousal and Subjective sexual arousal. Started Mar 2010; status: active.
02
Drugs
testosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)Sexual Arousal Disordersexual dysfunction
Beyond the preview
Go deeper on 2010-019540-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019540-39.